Days before the FDA approved the new bivalent Covid-19 vaccine boosters, Pascal Soriot, CEO of AstraZeneca, offered his own assessment of the need for such.
As had been widely expected, the US Food and Drug Administration (FDA) on Aug. 31 granted emergency use authorizations (EUAs) to the new Covid-19 shots developed by mRNA...
BioNTech and Pfizer are facing another lawsuit claiming that their Comirnaty-branded Covid-19 vaccine infringes another company’s patent. The latest to sue is US rival...
To meet surging global demand for its Jynneos-branded monkeypox vaccine, Danish biotech Bavarian Nordic (BN) is pulling out all stops. Strategies include outsourcing...
CureVac and GSK have announced they are launching a Phase 1 clinical trial with their modified mRNA-based Covid 19 vaccine CV051, which would be recommended as a booster...
It took longer than expected, but the US Food and Drug Administration (FDA) on July 13 finally granted an Emergency Authorization (EUA) to Nuaxovid, the protein-based...
The US Department of Health and Human Services (HHS) and the Department of Defense (DOD) have ordered 3.2 million doses of Novavax’s Covid-19 vaccine, even before the...
UK specialty chemical company Croda International will receive up to $75 million from the US government to expand its US capacity to produce ingredients for lipid systems...
